These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 25124827)

  • 1. Molecular imaging of plaque vulnerability.
    Tavakoli S; Vashist A; Sadeghi MM
    J Nucl Cardiol; 2014 Dec; 21(6):1112-28; quiz 1129. PubMed ID: 25124827
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Non-FDG imaging of atherosclerosis: will imaging of MMPs assess plaque vulnerability?
    Hermann S; Starsichova A; Waschkau B; Kuhlmann M; Wenning C; Schober O; Schäfers M
    J Nucl Cardiol; 2012 Jun; 19(3):609-17. PubMed ID: 22477642
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Atherosclerosis imaging on the molecular level.
    Bengel FM
    J Nucl Cardiol; 2006; 13(1):111-8. PubMed ID: 16464725
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Validation of FDG uptake in the arterial wall as an imaging biomarker of atherosclerotic plaques with 18F-fluorodeoxyglucose positron emission tomography-computed tomography (FDG-PET/CT).
    Bucci M; Aparici CM; Hawkins R; Bacharach S; Schrek C; Cheng S; Tong E; Arora S; Parati E; Wintermark M
    J Neuroimaging; 2014; 24(2):117-23. PubMed ID: 22928741
    [TBL] [Abstract][Full Text] [Related]  

  • 5. (18)F-FDG PET and vascular inflammation: time to refine the paradigm?
    Sadeghi MM
    J Nucl Cardiol; 2015 Apr; 22(2):319-24. PubMed ID: 24925623
    [No Abstract]   [Full Text] [Related]  

  • 6. [The progress of nuclear medicine and magnetic resonance molecular imaging of atherosclerotic vulnerable plaques].
    Zhao ZM; Qin SC
    Sheng Li Ke Xue Jin Zhan; 2011 Apr; 42(2):86-90. PubMed ID: 21770253
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [¹⁸F]-fluorodeoxyglucose PET imaging of atherosclerosis.
    Blomberg BA; Høilund-Carlsen PF
    PET Clin; 2015 Jan; 10(1):1-7. PubMed ID: 25455876
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of 68Ga-Glutamate Carboxypeptidase II Ligand Positron Emission Tomography for Clinical Molecular Imaging of Atherosclerotic Plaque Neovascularization.
    Derlin T; Thiele J; Weiberg D; Thackeray JT; Püschel K; Wester HJ; Aguirre Dávila L; Larena-Avellaneda A; Daum G; Bengel FM; Schumacher U
    Arterioscler Thromb Vasc Biol; 2016 Nov; 36(11):2213-2219. PubMed ID: 27609368
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular imaging of atherosclerosis with integrated PET imaging.
    Hammad B; Evans NR; Rudd JHF; Tawakol A
    J Nucl Cardiol; 2017 Jun; 24(3):938-943. PubMed ID: 28078575
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In Vivo PET Imaging of HDL in Multiple Atherosclerosis Models.
    Pérez-Medina C; Binderup T; Lobatto ME; Tang J; Calcagno C; Giesen L; Wessel CH; Witjes J; Ishino S; Baxter S; Zhao Y; Ramachandran S; Eldib M; Sánchez-Gaytán BL; Robson PM; Bini J; Granada JF; Fish KM; Stroes ES; Duivenvoorden R; Tsimikas S; Lewis JS; Reiner T; Fuster V; Kjær A; Fisher EA; Fayad ZA; Mulder WJ
    JACC Cardiovasc Imaging; 2016 Aug; 9(8):950-61. PubMed ID: 27236528
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Radiotracer Imaging of Peripheral Vascular Disease.
    Stacy MR; Zhou W; Sinusas AJ
    J Nucl Med Technol; 2015 Sep; 43(3):185-92. PubMed ID: 26338845
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In Vivo ¹⁸F-FDG-PET Imaging in Mouse Atherosclerosis.
    Mateo J; Bilbao I; Vaquero JJ; Ruiz-Cabello J; España S
    Methods Mol Biol; 2015; 1339():377-86. PubMed ID: 26445805
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of
    Nogales P; Velasco C; Mota-Cobián A; González-Cintado L; Mota RA; España S; Mateo J; Bentzon JF
    Arterioscler Thromb Vasc Biol; 2021 Oct; 41(10):e480-e490. PubMed ID: 34289703
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular imaging of atherosclerotic lesions by positron emission tomography - can it meet the expectations?
    Brammen L; Steiner S; Berent R; Sinzinger H
    Vasa; 2016; 45(2):125-32. PubMed ID: 27058798
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vivo alpha-V beta-3 integrin expression in human aortic atherosclerosis.
    Jenkins WS; Vesey AT; Vickers A; Neale A; Moles C; Connell M; Joshi NV; Lucatelli C; Fletcher AM; Spratt JC; Mirsadraee S; van Beek EJ; Rudd JH; Newby DE; Dweck MR
    Heart; 2019 Dec; 105(24):1868-1875. PubMed ID: 31422361
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Frontiers in positron emission tomography imaging of the vulnerable atherosclerotic plaque.
    MacAskill MG; Newby DE; Tavares AAS
    Cardiovasc Res; 2019 Dec; 115(14):1952-1962. PubMed ID: 31233100
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeting P-selectin by gallium-68-labeled fucoidan positron emission tomography for noninvasive characterization of vulnerable plaques: correlation with in vivo 17.6T MRI.
    Li X; Bauer W; Israel I; Kreissl MC; Weirather J; Richter D; Bauer E; Herold V; Jakob P; Buck A; Frantz S; Samnick S
    Arterioscler Thromb Vasc Biol; 2014 Aug; 34(8):1661-7. PubMed ID: 24903095
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular Imaging of Vulnerable Coronary Plaque: A Pathophysiologic Perspective.
    Krishnan S; Otaki Y; Doris M; Slipczuk L; Arnson Y; Rubeaux M; Dey D; Slomka P; Berman DS; Tamarappoo B
    J Nucl Med; 2017 Mar; 58(3):359-364. PubMed ID: 28183988
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    Creager MD; Hohl T; Hutcheson JD; Moss AJ; Schlotter F; Blaser MC; Park MA; Lee LH; Singh SA; Alcaide-Corral CJ; Tavares AAS; Newby DE; Kijewski MF; Aikawa M; Di Carli M; Dweck MR; Aikawa E
    Circ Cardiovasc Imaging; 2019 Jan; 12(1):e007835. PubMed ID: 30642216
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metabolic and Molecular Imaging of Atherosclerosis and Venous Thromboembolism.
    Osborn EA; Kessinger CW; Tawakol A; Jaffer FA
    J Nucl Med; 2017 Jun; 58(6):871-877. PubMed ID: 28450558
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.